Home

William B Hayes

CIK 1320940 · Chief Financial Officer, EVP · last filed 2026-06-02

William B Hayes is a Chief Financial Officer, EVP who has filed 89 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $38.7K of BLDR on Jun 2, 2026. Across all open-market trades the lifetime net is −$40.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.8M across reported positions. 49 SEC filings were submitted jointly with LABORATORY CORP OF AMERICA HOLDINGS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.84M

Companies

5

Total Filings

89

Lifetime Open-Market Net

-$40.07M

Filer Profile

Reported Address
231 MAPLE AVENUE
BURLINGTON, NC 27215
Related Filers
LABORATORY CORP OF AMERICA HOLDINGS — 49 joint filings, latest 2014-06-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BLDR Director 34,231 $60.37 $2.07M $0 33 2026-06-02
INDP Director — $2.77 — $0 6 2025-06-11
Intec Pharma Ltd. (NTEC) Delisted Director — $9.63 — $0 2 2020-07-17
Patheon N.V. (PTHN) Delisted Director 0 — — $0 4 2017-08-30
LH Chief Financial Officer, EVP 28,146 $311.54 $8.77M -$40.07M 44 2014-03-31

Recent Filings

89 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-02 BLDR Grant (A) +508 $38.7K EDGAR
2026-05-18 BLDR Grant (A) +2,558 $0 EDGAR
2026-03-03 BLDR Grant (A) +371 $38.7K EDGAR
2025-12-03 BLDR Grant (A) +345 $38.7K EDGAR
2025-09-03 BLDR Grant (A) +279 $38.7K EDGAR
2025-06-11 INDP Grant (A) — $0 EDGAR
2025-06-03 BLDR Grant (A) +359 $38.7K EDGAR
2025-05-29 BLDR Grant (A) +1,707 $0 EDGAR
2025-04-11 INDP Disp (D) — $0 EDGAR
2025-03-18 BLDR Grant (A) +269 $37.4K EDGAR
Showing 1–10 of 89
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.